Molecules,
Journal Year:
2024,
Volume and Issue:
29(24), P. 5893 - 5893
Published: Dec. 13, 2024
Bee
Pollen
(BP)
has
many
advantageous
properties
relying
on
its
multitargeting
potential,
a
new
tendency
in
managing
challenging
illnesses.
In
cancer
and
neurodegeneration,
the
multiple
effects
of
BP
could
be
unequaled
importance
need
further
investigation.
Although
still
limited,
available
data
interestingly
spotlights
some
floral
sources
with
promising
activities
line
this
Adopting
scoping
review
methodology,
we
have
identified
crucial
bioactivities
that
are
widely
recognized
to
individual
compounds
but
remain
completely
untapped
valuable
bee
cocktail.
A
wide
range
these
been
recently
found
endowed
great
potential
modulating
pivotal
processes
neurodegeneration
pathophysiology.
addition,
ubiquitous
only
isolated,
while
number
studied
BPs
remains
extremely
limited
compared
endless
pool
plant
species
worldwide.
We
also
elucidated
clinical
profits
from
perspectives
impeded
by
hurdles
such
as
bioavailability
phytocompounds,
diversity
lack
phytochemical
standardization
BP,
difficulty
selective
targeting
pathophysiological
mechanisms.
finally
present
interesting
insights
guide
future
research
pave
way
for
urgently
needed
simplified
investigations.
Frontiers in Medicine,
Journal Year:
2025,
Volume and Issue:
12
Published: April 9, 2025
This
Perspective
article
explores
the
challenges
associated
with
direct
application
of
photobiomodulation
(PBM)
to
gut
and
presents
a
novel
hypothesis
for
indirect
health
modulation
through
oral
microbiome
alteration.
Given
difficulties
in
delivering
PBM
effectively
deep
gastrointestinal
tissues,
an
alternative
approach
involves
targeting
microbiome,
which
has
demonstrated
relationship
microbiome.
Research
indicates
that
applied
cavity
could
selectively
alter
microbial
composition.
alteration
may,
via
oral-gut
axis,
indirectly
impact
health.
hypothesis,
supported
by
preliminary
studies,
suggests
offer
promising
non-invasive
strategy
managing
gut-related
disorders.
Furthermore,
there
may
be
link
between
brain
diseases.
proximity
brain,
PBM-induced
changes
microbiota
help
prevent
neurological
However,
further
investigation
is
necessary
comprehensively
elucidate
underlying
mechanisms
therapeutic
implications
this
approach.
Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(11), P. 2246 - 2246
Published: Nov. 6, 2024
Cardiovascular
diseases
(CVDs)
are
a
leading
cause
of
widespread
morbidity
and
mortality.
It
has
been
found
that
the
gut
oral
microbiomes
differ
in
individuals
with
CVDs
compared
to
healthy
individuals.
Patients
often
require
long-term
pharmacological
interventions.
While
these
medications
have
extensively
studied
for
their
cardiovascular
benefits,
emerging
research
indicates
they
may
also
impact
diversity
composition
microbiomes.
However,
our
understanding
how
factors
influence
compositions
remains
limited.
Studies
shown
statins
beta-blockers,
particular,
microbial
dysbiosis,
impacting
metabolism
absorption
medications.
These
alterations
can
lead
variations
drug
responses,
highlighting
need
personalized
treatment
approaches.
The
microbiome's
role
CVD
on
microbiome
crucial
variations.
there
very
few
studies
this
area,
not
all
studied,
emphasizing
necessity
further
conclusively
establish
cause-and-effect
relationships
determine
clinical
significance
interactions.
This
review
will
provide
evidence
patients
interact
specific
drugs
used
treatment.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Feb. 15, 2024
Aplastic
anemia
(AA)
and
hypoplastic
myelodysplastic
syndrome
are
paradigms
of
autoimmune
hematopoietic
failure
(AHF).
Myelodysplastic
acute
myeloid
leukemia
unequivocal
neoplasms
(MNs).
Currently,
AA
is
also
known
to
be
a
clonal
hematological
disease.
Genetic
aberrations
typically
observed
in
MNs
detected
approximately
one-third
patients.
In
patients
harboring
MN-related
genetic
aberrations,
poor
response
immunosuppressive
therapy
(IST)
an
increased
risk
transformation
occurring
either
naturally
or
after
IST
predicted.
Approximately
10%-15%
with
severe
transform
the
disease
phenotype
following
IST,
some
patients,
leukemic
emerges
during
shortly
IST.
Phenotypic
transformations
between
AHF
can
occur
reciprocally.
A
fraction
advanced
MN
experience
aplastic
crisis
which
blasts
repressed.
The
switch
that
shapes
change
strength
extramedullary
inflammation.
Both
have
immune-active
bone
marrow
(BM)
environment
(BME).
inflamed
BME
evoked
by
infiltrated
immune
cells
targeting
neoplastic
molecules,
contributes
BM-specific
impairment.
Autoimmune
responses
may
represent
antileukemic
mechanism,
inflammatory
stressors
strengthen
immunity,
at
least
significant
proportion
who
aberrations.
During
active
episodes,
normal
hematopoieses
suppressed,
leads
occurrence
cytopenia
cell
regression.
successful
treatment
underlying
infections
mitigates
stress-related
activities
promotes
penetration
hematopoiesis.
effect
similar
treating
infections.
Investigating
stress-powered
immunity
highly
important
theoretical
studies
clinical
practice,
especially
given
wide
application
immune-activating
agents
checkpoint
inhibitors
neoplasms.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(12), P. 2754 - 2754
Published: June 15, 2023
Dietary
deficiencies
in
zinc
(Zn)
and
vitamin
A
(VA)
are
among
the
leading
micronutrient
globally
previous
research
has
proposed
a
notable
interaction
between
Zn
VA
physiological
status.
This
study
aimed
to
assess
effects
of
(isolated
combined)
on
intestinal
functionality
morphology,
gut
microbiome
(Gallus
gallus).
The
included
nine
treatment
groups
(n~11)-no-injection
(NI);
H2O;
0.5%
oil;
normal
(40
mg/kg
ZnSO4)
(ZN);
low
(20
mg/kg)
(ZL);
retinoid
(1500
IU/kg
retinyl
palmitate)
(RN);
(100
IU/kg)
(RL);
mg/kg;
1500
(ZNRN);
(ZLRL)
100
IU/kg).
Samples
were
injected
into
amniotic
fluid
fertile
broiler
eggs.
Tissue
samples
collected
upon
hatch
target
biomarkers.
ZLRL
reduced
ZIP4
gene
expression
upregulated
ZnT1
(p
<
0.05).
Duodenal
surface
area
increased
greatest
RL
compared
RN
0.01),
ZNRN
All
nutrient
treatments
yielded
shorter
crypt
depths
0.01).
Compared
oil
control,
0.05)
cecal
abundance
Bifidobacterium
Clostridium
genera
These
results
suggest
potentially
improved
epithelium
proceeding
with
intra-amniotic
administration.
Intestinal
bacteria
modulated.
Further
should
characterize
long-term
responses
profile.
MQRInvestigar,
Journal Year:
2024,
Volume and Issue:
8(1), P. 5137 - 5168
Published: March 20, 2024
El
microbioma
intestinal
de
las
personas
obesas
suele
mostrar
diferencias
en
comparación
con
peso
normal.
Estas
pueden
estar
relacionadas
cambios
la
composición
y
diversidad
bacterias
que
viven
el
intestino,
así
como
función
del
microbioma.
Objetivo:
Analizar
regulación
su
impacto
obesidad.
Diseño
estudio:
La
metodología
aplicada
fue
revisión
bibliográfica.
Búsqueda
información:
Se
logró
acceder
mediante
buscadores
científicos
PubMed
Central;
Scielo,
Google
académico.
Resultados:
pudo
obtener
esta
enfermedad
altera
homeostasis
ser
humano.
Provoca
enfermedades
inflamatorias,
autoinmunes,
metabólicas
neoplásicas,
algunos
trastornos
conducta.
También
se
encontró
metabolismo,
absorción
nutrientes,
recolección
energía
dieta,
también
regula
sistema
inmunológico.
obtuvieron
resultados
los
probióticos
usan
para
regular
microbiota
endógena,
mayor
uso
son
siguientes
modular
funciones
influyen
al
mejorar
metabolismo
energético
lipólisis.
Conclusión:
ha
demostrado
está
relacionada
incluida
capacidad
cuerpo
alimentos.
Frontiers in Aging Neuroscience,
Journal Year:
2024,
Volume and Issue:
16
Published: Dec. 3, 2024
Alzheimer’s
Disease
(AD)
is
a
neurodegenerative
disorder
marked
by
cognitive
decline,
for
which
effective
treatments
remain
elusive
due
to
complex
pathogenesis.
Recent
advances
in
neuroimaging,
gene
therapy,
and
gut
microbiota
research
offer
new
insights
potential
intervention
strategies.
Neuroimaging
enables
early
detection
staging
of
AD
through
visualization
biomarkers,
aiding
diagnosis
tracking
disease
progression.
Gene
therapy
presents
promising
approach
modifying
AD-related
genetic
expressions,
targeting
amyloid
tau
pathology,
potentially
repairing
neuronal
damage.
Furthermore,
emerging
evidence
suggests
that
the
influences
pathology
gut-brain
axis,
impacting
inflammation,
immune
response,
metabolism.
However,
each
these
technologies
faces
significant
challenges,
including
concerns
about
safety,
efficacy,
ethical
considerations.
This
article
reviews
applications,
advantages,
limitations
AD,
with
particular
focus
on
their
combined
diagnosis,
mechanistic
insights,
therapeutic
interventions.
We
propose
an
integrated
leverages
tools
provide
multi-dimensional
framework
advancing
treatment,
prevention.
Journal of Applied Microbiology,
Journal Year:
2023,
Volume and Issue:
134(12)
Published: Nov. 24, 2023
Abstract
Metagenome
sequencing
techniques
revolutionized
the
field
of
gut
microbiome
study.
However,
it
is
equipped
with
experimental
and
computational
biases,
which
affect
downstream
analysis
results.
Also,
live
microbial
strains
are
needed
for
a
better
understanding
host-microbial
crosstalks
designing
next-generation
treatment
therapies
based
on
probiotic
postbiotic
molecules.
Conventional
culturing
methodologies
insufficient
to
get
dark
matter
plate;
therefore,
there
an
urgent
need
propose
novel
methods
that
can
fill
limitations
metagenomics.
The
current
work
aims
provide
consolidated
evaluation
available
host-microbe
interaction
emphasis
in
vitro
microbes
using
organoids,
chip,
bioreactor.
Further,
knowledge
crosstalk
helps
us
identify
core
microbiota,
key
metabolites
will
aid
media
co-culturing
systems
After
deeper
mining
methods,
we
recommend
3D-printed
intestinal
cells
multistage
continuous
flow
reactor
extended
organoid
system
might
be
good
practical
choice
microbiota-based
studies.